Vivanza Biosciences Ltd, initially established as Ivee Injectaa Limited in 1982, is a pharmaceutical company headquartered in Gujarat, India. Transitioning from a private to a public entity in 1992, the company rebranded to its current name in 2015. Vivanza focuses on producing high-quality pharmaceuticals at competitive prices and has expanded its manufacturing capacity from 18 lac to 54 lac units annually. Additionally, it plans to diversify into small volume parenterals with an installed capacity of 294 lac units annually. The company is notable for utilizing both glass and plastic containers in its production.
Vivanza has set its sights on global markets, aiming to supply and execute turnkey pharmaceutical projects. The acquisition of Vivanza Lifesciences Private Limited in 2016 marked a strategic move to fortify its market position. Despite facing industry challenges in 1999-2000, the company continues to adopt new technologies and enhance its manufacturing capabilities to stay competitive in the evolving pharmaceutical landscape.